Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Keklik M, Deveci B, Celik S, Deniz K, Gonen ZB, Zararsiz G, Saba R, Akyol G, Ozkul Y, Kaynar L, Keklik E, Unal A, Cetin M, Jones OY. Keklik M, et al. Among authors: deveci b. Ann Hematol. 2023 Jun;102(6):1537-1547. doi: 10.1007/s00277-023-05216-3. Epub 2023 Apr 17. Ann Hematol. 2023. PMID: 37067556
Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish hematology research and education group (ThREG).
Soyer N, Gunduz M, Tekgunduz E, Deveci B, Ozdogu H, Sahin HH, Turak EE, Okay M, Kuku I, Hindilerden IY, Topcuoglu P, Altuntas F, Karadogan I, Pehlivan M, Unal A, Goker H, Erkurt MA, Besısık SK, Vural F; ThREG (Turkish Hematology Research). Soyer N, et al. Among authors: deveci b. Transfus Apher Sci. 2020 Aug;59(4):102827. doi: 10.1016/j.transci.2020.102827. Epub 2020 May 26. Transfus Apher Sci. 2020. PMID: 32522474
Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria with or without Aplastic Anemia: A Multicenter Turkish Experience.
Yılmaz F, Soyer N, Cengiz Seval G, Civriz Bozdağ S, Topcuoğlu P, Ünal A, Kaynar L, Özgür G, Sucak G, Göker H, Velet M, Özdoğu H, Yılmaz M, Kaya E, Salim O, Deveci B, Karadoğan İ, Saydam G, Şahin F, Vural F. Yılmaz F, et al. Among authors: deveci b. Turk J Haematol. 2021 Aug 25;38(3):195-203. doi: 10.4274/tjh.galenos.2021.2021.0105. Epub 2021 May 31. Turk J Haematol. 2021. PMID: 34057336 Free PMC article.
Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data.
Tombak A, Pepedil Tanrıkulu F, Durusoy SS, Dinçyürek HD, Kaya E, Ümit EG, Yavaşoğlu İ, Mehtap Ö, Deveci B, Özcan MA, Terzi H, Okay M, Sayınalp N, Yılmaz M, Okan V, Kızıklı A, Özcan Ö, Çetin G, Demircioğlu S, Aydoğdu İ, Saydam G, Davulcu EA, İlhan G, Uçar MA, Özet G, Akpınar S, Turgut B, Berber İ, Kurtoğlu E, Sönmez M, Batur DS, Yıldırım R, Özkocamaz V, Güneş AK, Sahip B, Ertop Ş, Akay OM, Baştürk A, Doğu MH, Akdeniz A, Ünal A, Seyhanlı A, Gürkan E, Çekdemir D, Ferhanoğlu B. Tombak A, et al. Among authors: deveci b. Turk J Haematol. 2021 Dec 7;38(4):273-285. doi: 10.4274/tjh.galenos.2021.2021.0007. Epub 2021 Aug 27. Turk J Haematol. 2021. PMID: 34448556 Free PMC article.
Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey.
Dal MS, Ulu BU, Uzay A, Akay OM, Beşışık S, Yenerel MN, Çelik S, Kaynar L, Yücel OK, Deveci B, Sönmez M, Mehtap Ö, Beköz HS, Sunu C, Salim O, Ulaş T, Kartı S, Altuntaş F, Ferhanoğlu B, Tuğlular TF. Dal MS, et al. Among authors: deveci b. Ann Hematol. 2023 Jan;102(1):133-140. doi: 10.1007/s00277-022-05052-x. Epub 2022 Nov 19. Ann Hematol. 2023. PMID: 36401621 Free PMC article.
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.
Birtas Atesoglu E, Gulbas Z, Uzay A, Ozcan M, Ozkalemkas F, Dal MS, Kalyon H, Akay OM, Deveci B, Bekoz H, Sevindik OG, Toptas T, Yilmaz F, Koyun D, Alkis N, Alacacioglu I, Sonmez M, Yavasoglu I, Tombak A, Mehtap O, Kurnaz F, Yuce OK, Karakus V, Turgut M, Kurekci DD, Ayer M, Keklik M, Buyuktas D, Ozbalak M, Ferhanoglu B. Birtas Atesoglu E, et al. Among authors: deveci b. Hematol Oncol. 2023 Oct;41(4):663-673. doi: 10.1002/hon.3174. Epub 2023 May 22. Hematol Oncol. 2023. PMID: 37211991
70 results